πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 677 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8106027

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101739

Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) ang

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8088379

Modified T cell receptors and related materials and methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084199

Method of diagnosing poor survival prognosis colon cancer using microRNA-21

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075903

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076100

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071084

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071113

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067530

Scytovirin domain 1 related polypeptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8053422

Anti-cancer oligodeoxynucleotides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8053443

N-substituted indenoisoquinolines and syntheses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8044189

Bacillus anthracis protective antigen nucleic acid sequences

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8039585

Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8030285

Oligodeoxynucleotide and its use to induce an immune response

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8017130

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8008266

Methods of treating cancer using immunostimulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7998736

Adoptive immunotherapy with enhanced T lymphocyte survival

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7993921

Cell cycle regulation and differentiation

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7993919

Method of inducing memory B cell development and terminal differentiation

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7993857

Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7988971

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7981610

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphom

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7977468

Chromosome 3p21.3 genes are tumor suppressors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7972606

T24 antigen for immunodiagnosis of Taenia solium cysticercosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted